Facundo Zaffaroni
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer.
Journal: Breast cancer research : BCR
Published: January 03, 2026
Factors associated with accepting chemotherapy despite the risk of fertility loss in Latin American breast cancer patients-LACOG 0414 study.
Journal: Therapeutic advances in medical oncology
Published: February 28, 2025
Clinical validation and diagnostic accuracy of 99mTc-EDDA/HYNIC-TOC compared to 111In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study.
Journal: Ecancermedicalscience
Published: September 30, 2022
Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 'CaboGIST'.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 28, 2022
Influence of physician's lifestyle on the prescription of healthy habits to breast cancer patients (LACOG 1218).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 15, 2021
Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trial.
Journal: Cancer
Published: August 23, 2021
Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 26, 2021
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
Journal: JAMA surgery
Published: April 03, 2020
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
Journal: Breast cancer research and treatment
Published: February 29, 2020
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 06, 2020
Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115).
Journal: Journal of global oncology
Published: November 16, 2019
Health-related quality of life before and during chemotherapy in patients with early-stage breast cancer.
Journal: Ecancermedicalscience
Published: October 24, 2019
Last Updated: 09/26/2026